| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |